Medpace Holdings, INC Form 4 insider transactions

Medpace Holdings CEO August J. Troendle indirectly sold 100,000 shares of common stock through Medpace Investors, LLC on February 29 and March 1, 2024.

Stephen P. Ewald, General Counsel & Corp. Secy. of Medpace Holdings, Inc., sold shares of common stock to cover tax withholding obligations and for general trading.

Jesse J. Geiger, President of Medpace Holdings, Inc., sold 2,558 shares of common stock on February 29, 2024, to satisfy tax withholding obligations.

Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold 500 shares of common stock on February 28, 2024.

Medpace Holdings CEO August J. Troendle, through Medpace Investors, LLC, sold 100,000 shares of common stock in two days at weighted average prices of $401.88 and $404.13.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold 100,000 shares of common stock in two transactions on February 27 and 28, 2024.

Ashley M. Keating, a director at Medpace Holdings, exercised stock options and sold shares on February 26, 2024, according to a Form 4 filing with the SEC.

Medpace Holdings CEO August J. Troendle reports the sale of company stock through Medpace Investors, LLC.

Medpace Investors, LLC, a 10% owner of Medpace Holdings, Inc., sold a significant number of shares in two transactions on February 23 and 26, 2024.